Colon Cancer
20190135: A Phase 1b Study Evaluating the Safety, Tolerability, and Efficacy of Sotorasib in Combination with MVASI® and FOLFIRI and in Combination with MVASI® and FOLFOX in Subjects with Advanced Colorectal Cancer with KRAS p.G12C Mutation (CodeBreak 101 Subprotocol M)
- Details
ClinicalTrials.gov ID:
NCT04185883
Diagnosis Type:
NA
USOR Number:
- Address
,
P: